Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02659475 · ClinicalTrials.gov registry record · Phase 2
Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)
A Phase 2 study, sponsored by Lindner Center of HOPE.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT02659475: Completed Phase 2 study, sponsored by Lindner Center of HOPE.
NCT02659475 is a Phase 2 study that has completed, run by Lindner Center of HOPE. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02659475, a Phase 2 study, has completed, sponsored by Lindner Center of HOPE.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this project is to evaluate the effectiveness and tolerability of the novel weight management medication PHEN/TPM ER (Qsymia®)along with nutritional and lifestyle modification counseling in the treatment of binge eating disorder (BED) in overweight or obese individuals.
Primary Outcome
Weight will be measured at all study visits - screen, baseline (week 0), and weeks 2, 4, 6, 8, 10. 12
Interventions
- DRUG PHEN/TPM ER (Qsymia®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
What the finished NCT02659475 record still lists
NCT02659475 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which PHEN/TPM ER (Qsymia®) is the first listed.
NCT02659475 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02659475 about?
NCT02659475 is a clinical study titled "Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)". The goal of this project is to evaluate the effectiveness and tolerability of the novel weight management medication PHEN/TPM ER (Qsymia®)along with nutritional and lifestyle modification counseling in the treatment of binge eating disorder (BED) in overweight or obese individuals.
What is the current status of trial NCT02659475?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2015-09. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02659475?
The interventions under investigation include: PHEN/TPM ER (Qsymia®) (DRUG).
Who is sponsoring clinical trial NCT02659475?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02659475's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia